Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05RKH
|
||||
| Former ID |
DNC010249
|
||||
| Drug Name |
6-methyl-4-(piperazin-1-yl)furo[2,3-d]pyrimidine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530516] | ||
| Formula |
C11H14N4O
|
||||
| Canonical SMILES |
CC1=CC2=C(N=CN=C2O1)N3CCNCC3
|
||||
| InChI |
1S/C11H14N4O/c1-8-6-9-10(13-7-14-11(9)16-8)15-4-2-12-3-5-15/h6-7,12H,2-5H2,1H3
|
||||
| InChIKey |
MNCCXFCOQHVIEX-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [530516] | |
| PANTHER Pathway | 5HT2 type receptor mediated signaling pathway | ||||
| References | |||||